Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Ching Lo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Neuroscience|March 29, 2011
Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3βJihoon Jo, Daniel J Whitcomb, Kimberly Moore Olsen, et al.
Gene Therapy|February 9, 2021
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in miceSam Hana, Michael Peterson, Helen McLaughlin, et al.
Scientific Reports|July 2, 2025
Engineered microRNA scaffolds for potent gene silencing in vivoGiuseppe Militello, Alyssa Greig, Chongfeng Bi, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Cis-regulatory elements driving motor neuron-restricted viral payload expression within the mammalian spinal cordM Aurel Nagy, Spencer Price, Kristina Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Cis-regulatory elements driving motor neuron-selective viral payload expression within the mammalian spinal cordM Aurel Nagy, Spencer Price, Kristina Wang, et al.
Molecular Therapy. Nucleic Acids|November 6, 2023
Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selectionShukkwan K Chen, Zachary C E Hawley, Maria I Zavodszky, et al.
Acta Neuropathologica Communications|May 24, 2025
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1<sup>C71G</sup> ALS mouse modelZachary C E Hawley, Xueying Li, Dora Bodnar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and miceZachary C E Hawley, Ingrid D Pardo, Shaolong Cao, et al.
Gene Therapy|November 30, 2022
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse modelYi A Chen, Mark W Kankel, Sam Hana, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2025
Inhibition of immune response reduces pathology in dorsal root ganglia and peripheral nerves in cynomolgus macaques following AAV gene therapyBranka Grubor, Kate L Henry, Su Jing Chan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Neuroscience|March 29, 2011
Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3βJihoon Jo, Daniel J Whitcomb, Kimberly Moore Olsen, et al.
Gene Therapy|February 9, 2021
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in miceSam Hana, Michael Peterson, Helen McLaughlin, et al.
Scientific Reports|July 2, 2025
Engineered microRNA scaffolds for potent gene silencing in vivoGiuseppe Militello, Alyssa Greig, Chongfeng Bi, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Cis-regulatory elements driving motor neuron-restricted viral payload expression within the mammalian spinal cordM Aurel Nagy, Spencer Price, Kristina Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Cis-regulatory elements driving motor neuron-selective viral payload expression within the mammalian spinal cordM Aurel Nagy, Spencer Price, Kristina Wang, et al.
Molecular Therapy. Nucleic Acids|November 6, 2023
Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selectionShukkwan K Chen, Zachary C E Hawley, Maria I Zavodszky, et al.
Acta Neuropathologica Communications|May 24, 2025
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1<sup>C71G</sup> ALS mouse modelZachary C E Hawley, Xueying Li, Dora Bodnar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and miceZachary C E Hawley, Ingrid D Pardo, Shaolong Cao, et al.
Gene Therapy|November 30, 2022
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse modelYi A Chen, Mark W Kankel, Sam Hana, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2025
Inhibition of immune response reduces pathology in dorsal root ganglia and peripheral nerves in cynomolgus macaques following AAV gene therapyBranka Grubor, Kate L Henry, Su Jing Chan, et al.
Pageof 3